Computer Vision Syndrome Prevalence Among University Students

December 21, 2022 updated by: Prof. Mohammed Iqbal, Sohag University

Prevalence and Severity of Computer Vision Syndrome Among Medical Students

CVS-F3 questionnaire will be used as an instrument to survey CVS prevalence and severity among medical students

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

CVS-F3 is a valid questionnaire that includes 26 questions to be responded by the medical students to detect CVS complains and possible complications. The questionnaire includes questions regarding potential ocular, extra-ocular, musclo-skeletal and neuro-psychatric complains caused by CVS. Complete statistical analysis of the survey data will be done using univariate and multivariate logistic and linear regression analysis.

Study Type

Observational

Enrollment (Actual)

49

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Sohag, Egypt, 82425
        • Faculty of medicine
      • Sohag, Egypt, 82425
        • Sohag Faculty of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

medical students who are using screens in their medical studies or personal lives and how these screens affect their medical studies and the effect of mandated medical computer use if present on their screen-behaviour and associated risk factor

Description

Inclusion Criteria:

  • university students
  • studying medicine

Exclusion Criteria:

  • ocular surgery
  • amblyopia
  • anisometropia
  • strabismus
  • DM
  • hypertension

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of CVS
Time Frame: 1 month
will be reorted in form of percentage (%) of students with CVS
1 month
Visual acuity
Time Frame: 1 month
measurement of visual acuity using distance visual charts in logMAR measurements
1 month
Refraction
Time Frame: 1 month
measurement of refractive power in diopters
1 month
Schirmer test
Time Frame: 1 month
measurement of tear volume production with Schirmer test in mm unit measurements
1 month
Tear Break Up Time (TBUT)
Time Frame: 1 month
measurement of tear film stability with TBUT in seconds time unit measurements
1 month
mfERG examinations
Time Frame: 6 months
mfERG will be performed for the students to document the effect of CVS on retina
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mohammed Iqbal, Sohag University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 28, 2020

Primary Completion (Actual)

October 20, 2020

Study Completion (Actual)

December 31, 2020

Study Registration Dates

First Submitted

May 24, 2020

First Submitted That Met QC Criteria

May 24, 2020

First Posted (Actual)

May 28, 2020

Study Record Updates

Last Update Posted (Estimate)

December 22, 2022

Last Update Submitted That Met QC Criteria

December 21, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 4-8/1/2018

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Computer Vision Syndrome

Clinical Trials on CVS GROUP

3
Subscribe